The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries

Stefan Flasche and colleagues consider whether the number of PCV doses in the infant schedule could be reduced without compromising its public health benefit in high-income settings.

[1]  G. Garnett,et al.  ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES , 2006 .

[2]  M. Lipsitch,et al.  Pneumococcal Carriage and Antibiotic Resistance in Young Children Before 13-valent Conjugate Vaccine , 2012, The Pediatric infectious disease journal.

[3]  K. O'Brien,et al.  Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage , 2013, The Pediatric infectious disease journal.

[4]  David Goldblatt,et al.  Immunogenicity of, and Immunologic Memory to, a Reduced Primary Schedule of Meningococcal C-Tetanus Toxoid Conjugate Vaccine in Infants in the United Kingdom , 2003, Infection and Immunity.

[5]  Dallas,et al.  Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[6]  N. Andrews,et al.  Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. , 2014, The Lancet. Infectious diseases.

[7]  K. O'Brien,et al.  Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  N. Andrews,et al.  Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United Kingdom , 2010, The Pediatric infectious disease journal.

[9]  N. Andrews,et al.  Immunogenicity and Boosting After a Reduced Number of Doses of a Pneumococcal Conjugate Vaccine in Infants and Toddlers , 2006, The Pediatric infectious disease journal.

[10]  T. Cherian,et al.  Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites , 2013, PLoS medicine.

[11]  W. Edmunds,et al.  Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis , 2012, BMJ : British Medical Journal.

[12]  D. Greenberg,et al.  The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial. , 2012, Vaccine.

[13]  S. Madhi,et al.  A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. , 2003, The New England journal of medicine.